Jeffrey M Gross Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey M Gross.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey M Gross. Jeffrey M Gross is Senior VP, R & D in ANGIOTECH PHARMACEUTICALS INC ($ANPI) and Sr VP, Research & Development in ANGIOTECH PHARMACEUTICALS INC ($ANPI) and SVP, Research & Development in ANGIOTECH PHARMACEUTICALS INC ($ANPI) and SVP, Research and Development in ANGIOTECH PHARMACEUTICALS INC ($ANPI).
Latest Insider Trading Transactions of Jeffrey M Gross
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Option Exercise | J | 7.61 | 25,000 | 190,250 | 0 | |
| May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Option Exercise | J | 0.21 | 100,000 | 21,000 | 25,000 | |
| May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Option Exercise | J | 0.38 | 150,000 | 57,000 | 125,000 | |
| May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Option Exercise | J | 1.09 | 85,000 | 92,650 | 275,000 | |
| May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Sell | J | 1.85 | 12,500 | 23,125 | 0 | 12.5 K to 0 (-100.00 %) |
| May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Sell | J | 1.77 | 20,000 | 35,400 | 12,500 | 32.5 K to 12.5 K (-61.54 %) |
| May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Sell | J | 1.80 | 2,000 | 3,600 | 32,500 | 34.5 K to 32.5 K (-5.80 %) |
| May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Sell | J | 1.72 | 1,500 | 2,580 | 34,500 | 36 K to 34.5 K (-4.17 %) |
| May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Sell | J | 1.68 | 6,000 | 10,080 | 36,000 | 42 K to 36 K (-14.29 %) |
| May 16 2011 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Sell | J | 1.11 | 9,000 | 9,990 | 42,000 | 51 K to 42 K (-17.65 %) |
| Mar 26 2010 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Buy | P | 1.11 | 9,000 | 9,990 | 51,000 | 42 K to 51 K (+21.43 %) |
| Mar 09 2010 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Option Exercise | A | 1.09 | 85,000 | 92,650 | 360,000 | |
| Aug 31 2009 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Buy | P | 1.68 | 6,000 | 10,080 | 36,600 | 30.6 K to 36.6 K (+19.61 %) |
| Aug 14 2009 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Buy | P | 1.72 | 1,500 | 2,580 | 36,000 | 34.5 K to 36 K (+4.35 %) |
| Aug 14 2009 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Buy | P | 1.80 | 2,000 | 3,600 | 34,500 | 32.5 K to 34.5 K (+6.15 %) |
| Jun 18 2009 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research & Dev ... | Buy | P | 1.85 | 12,500 | 23,125 | 12,500 | 0 to 12.5 K |
| Jun 23 2009 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | SVP, Research and D ... | Buy | P | 1.77 | 20,000 | 35,400 | 32,500 | 12.5 K to 32.5 K (+160.00 %) |
| Mar 11 2009 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | Sr VP, Research & D ... | Option Exercise | A | 0.38 | 150,000 | 57,000 | 275,000 | |
| Dec 10 2008 | ANPI | ANGIOTECH PHARMACE ... | Gross Jeffrey M | Senior VP, R & D | Option Exercise | A | 0.21 | 100,000 | 21,000 | 125,000 |
Page: 1